Navigation Links
AllCells Introduces Autoimmune Diseased Cells and Tissue Products
Date:9/11/2012

EMERYVILLE, Calif., Sept. 11, 2012 /PRNewswire/ -- AllCells, LLC, a leading provider of healthy & diseased hematopoietic tissues, primary cell types, and related services to the global life science industry has announced the release of new autoimmune diseased cells and tissue products. The specimens may be used in preclinical research, drug discovery, drug toxicity, diagnostic related assays, and other life science research applications. All products are indicated for in vitro research use only.

"The introduction of this autoimmune product line fulfills a vital need by our customers to obtain hematologic samples from a variety of autoimmune indications. These products serve as essential components of cell-based assays commonly used in the work-flow of our customers' preclinical research projects," commented Eric Martinelli, Business Development Manager.  

AllCells provides peripheral blood and/or isolated cell types from patients diagnosed with Autoimmune diseases such as  Rheumatoid Arthritis, Osteoarthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Type I & Type II Diabetes, and Multiple Sclerosis. Autoimmune plasma and peripheral blood mononuclear cells are available from each disease type.

Patient treatment history and clinical reports are available for each sample, and may include auto antibody analysis and/or clinical diagnostic scores (ACR, SLEDAI, etc.). Autoimmune Diseased Cells & Tissue products are obtained from volunteers participating in an Institutional Review Board (IRB) or Human Subject Committee approved donor program. All donors sign an informed consent form, and are screened for infectious diseases (HIV, Hepatitis B & C).

For more information about autoimmune diseased cells and tissue specimens, visit www.AllCells.com.

Full release available here:  http://www.allcells.com/blog/allcells-introduces-autoimmune-diseased-cells-and-tissue-products/.    

About AllCells, LLC
AllCells, LLC is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.


'/>"/>
SOURCE AllCells, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. AllCells, LLC Named to Inc. Magazines 500/5000 List of Fastest Growing Companies
2. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
3. JPSA Introduces Picosecond Laser Micromachining System
4. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
5. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
6. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
7. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
8. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
9. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
10. Genalyte Launches Maverick ENA Kits For Fast, Easy And Accurate Multiplexed Autoimmune Testing
11. Stem Cells Bring New Hope for Parry-Romberg Syndrome Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... II Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). ... two years to develop a suite of BioGel™ biopolymer materials for hygiene applications, ...
(Date:3/28/2017)... 2017  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member. David Cox ... North America ), will serve as his ... "We,re pleased to have Ipsen and Dr. Cox join ... . "We welcome their insights in helping us identify ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently ... over time. A recent study published in STEM CELLS suggests that human neural ... (SVZ) stem cells to produce more neural cells. , Strategies involving transplantation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Executive search ... with Avomeen Analytical Services. Harvill is a distinguished life sciences expert with a ... is a leader in a wide range of services related to laboratory testing ...
Breaking Biology Technology:
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/22/2017)... 2017 Vigilant Solutions , a vehicle ... agencies, announced today the appointment of retired FBI special ... safety business development. Mr. Sheridan brings more ... a focus on the aviation transportation sector, to his ... Mr. Sheridan served as the Aviation Liaison Agent Coordinator ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
Breaking Biology News(10 mins):